LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE)

businesswire

LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) – NEWSnet – News… as it used to be

More Press Releases

June 10, 2026

VERI Investors Have Opportunity to Lead Veritone, Inc. Securities Fraud Lawsuit

June 10, 2026

Veteran-Owned Anchor and Watch Coffee Standard Calls on Coffee Lovers Everywhere to Join a Growing Movement That Honors Service

June 10, 2026

Alexander Hall Leads a New Wave of Christian Ministry by Bridging Faith, Media, and Practical Discipleship for a Disconnected Generation

June 10, 2026

LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE)

VERI Investors Have Opportunity to Lead Veritone, Inc. Securities Fraud Lawsuit

Veteran-Owned Anchor and Watch Coffee Standard Calls on Coffee Lovers Everywhere to Join a Growing Movement That Honors Service

Alexander Hall Leads a New Wave of Christian Ministry by Bridging Faith, Media, and Practical Discipleship for a Disconnected Generation

Kool Climate HVAC Services, LLC Strengthens Regional Temperature Management Standards